Baxter Healthcare BioPharma Solutions Generic Pharmaceuticals
Closed State & local contract opportunity Posted
- Solicitation number
- 2136889
- State
- New York
- Responses due
Opportunity facts
- Jurisdiction
- Points of contact
-
- Zhong Yi Hu zhongyi.hu2@stonybrookmedicine.edu (631) 444-4036
- Marilou Ferrara marilou.ferrara@stonybrookmedicine.edu (631) 444-4055
Updated .
About this opportunity
Stony Brook University Hospital is soliciting proposals for Baxter Healthcare BioPharma Solutions generic pharmaceuticals under a five-year cooperative purchasing vehicle through Premier, with proposals due July 28, 2026. This procurement bypasses formal competition under New York State Finance Law section 163(3)(vi), which permits purchases from a consortium entity when justified by price; vendors offering equivalent products may contact the listed officer to discuss participation.
The contract term runs from July 6, 2026 through June 30, 2031. Baxter Healthcare Corp BioPharma Solutions is identified as the business enterprise awarded an identical or substantially similar contract within the past five years.
Bidders are subject to New York State Finance Law sections 139(j) and (k) (the Lobbying Law), which restrict vendor contact to the designated procurement officer; violations can result in contract denial or debarment from sales to any state agency. Successful contractors must complete vendor-responsibility documentation, NYS Finance Law 139 certifications, NYS Tax Law Section 5-a compliance, and submit valid current NYS Workers' Compensation and Disability forms. All proposals must be received by close of business on the due date.
Opportunity text
Stony Brook University Hospital intends to purchase Baxter Healthcare BioPharma Solutions Generic Pharmaceuticals Products from a contract awarded by Premier pursuant to their authority under section 163(3)(vi), which authorizes the purchase of commodities from a consortium or comparable entity in lieu of using a centralized contract and without a formal competitive process when justified by price. Vendors who sell the equivalent Baxter Healthcare BioPharma Solutions Generic Pharmaceuticals Products may, if interested, contact the Officer listed below to discuss the procurement. The initial term will be for 5 years, from 7/6/26 to 6/30/31. This procurement is subject to NYS Finance Law §139 j&k, AKA the Lobbying Law. Therefore, vendors are cautioned that the only permissible contact for this procurement is the individual listed below. Failure to comply with this requirement can range from no contract to debarment from sales to any NYS Agency. Successful contractor shall be required to complete and submit documents related to Vendor Responsibility, NYS Finance Law 139, NYS Tax Law Section 5-a, and valid/current NYS Workers' Compensation and Disability Forms. If you propose to submit a bid, it must be received by COB of the due date listed. Business enterprises awarded an identical or substantially similar procurement contract within the past five years: Baxter Healthcare Corp BioPharma Solutions
On GovTribe
Work this opportunity
- Track it in your pipeline
- Similar opportunities
- Ask GovTribe AI about this opportunity